Temple syndrome due to paternal 14q32.2 microdeletion is a rare genetic condition that affects growth, development, and hormones. Early signs of Temple syndrome due to paternal 14q32.2 microdeletion often appear before birth or in infancy and can include poor growth, low muscle tone, and feeding problems. Many living with Temple syndrome also have short stature, smaller hands and feet, early puberty, and mild learning or behavior differences, but not everyone will have the same experience. It is a lifelong condition, and people with Temple syndrome are often recognized in childhood, although some are diagnosed later. Treatment focuses on support rather than cure and may include nutrition help, physical and developmental therapies, and hormone or puberty care, and life expectancy is often thought to be near normal when medical needs are managed.
How many people live with Temple syndrome due to paternal 14q32.2 microdeletion?
Worldwide and U.S. population estimates for Temple syndrome caused by a small missing piece of chromosome 14 from the father, called a paternal 14q32.2 microdeletion, are not consistently reported by a single authoritative source. Temple syndrome is considered ultra-rare, and this deletion form is only one of several known genetic causes, so no reliable global or U.S. headcount is available.
Overview
Temple syndrome due to paternal 14q32.2 microdeletionSymptoms
Temple syndrome due to paternal 14q32.2 microdeletion often causes poor growth before and after birth, low muscle tone, and feeding problems early in life. Many living with Temple syndrome also have short height, early puberty, and learning or behavior differences.
Outlook and prognosis
Temple syndrome due to paternal 14q32.2 microdeletion is lifelong, but many people do well with early support for growth, puberty, learning, and behavior. Outlook varies, and regular follow-up can help people stay healthy and more independent over time.
Causes and risk factors
Temple syndrome due to paternal 14q32.2 microdeletion happens when a small piece of chromosome 14 is missing on the father-linked copy, usually as a new genetic change and less often inherited. Family history can raise the chance.
Genetic influences
Genetics are central to Temple syndrome due to paternal 14q32.2 microdeletion, because it results from changes in a specific region of chromosome 14. Most cases are not caused by lifestyle or environment, though the exact genetic change can vary between families.
Diagnosis
Temple syndrome due to paternal 14q32.2 microdeletion is diagnosed by combining clinical features with genetic tests. Doctors may suspect it from growth and puberty patterns, then confirm the diagnosis of Temple syndrome with chromosome microarray or related DNA testing.
Treatment and drugs
Temple syndrome due to paternal 14q32.2 microdeletion is treated by managing each child’s needs, often with feeding support, physical therapy, and help for learning or behavior. Doctors watch growth, weight, and early puberty, and some children benefit from hormone treatment.
Symptoms
Temple syndrome due to paternal 14q32.2 microdeletion often shows up as slow growth, low muscle tone, feeding trouble in infancy, and puberty that starts earlier than expected. The early features of Temple syndrome due to paternal 14q32.2 microdeletion can be easy to miss because some overlap with common childhood concerns. Features vary from person to person and can become more noticeable over time.
Many babies grow more slowly during pregnancy and are born smaller than expected. This often means a lower birth weight and shorter length at birth.
Low muscle tone can make feeding feel tiring and slow in the first months of life. Babies may have a weak suck, take a long time to feed, or need extra support to gain weight.
Because the muscles may feel less firm, sitting, crawling, and walking can happen later than expected. Some children also seem less steady on stairs, playground equipment, or during sports.
Many children with Temple syndrome due to paternal 14q32.2 microdeletion remain shorter than expected as they grow. Adult height may also be below the family average.
How people usually first notice Temple syndrome due to paternal 14q32.2 microdeletion?
Temple syndrome due to a paternal 14q32.2 microdeletion is often first noticed before birth or in the newborn period, when doctors may see slow growth in pregnancy, low birth weight, low muscle tone, or feeding difficulties. As infancy and early childhood unfold, the first signs of Temple syndrome can include poor growth, delays in sitting, walking, or speech, and later a pattern of early puberty or rapid weight gain that seems out of step with other children. Because these signs can be subtle and vary from child to child, many families first realize something is going on through a combination of growth concerns, developmental differences, and routine medical checkups rather than one single dramatic warning sign.
Types of Temple syndrome due to paternal 14q32.2 microdeletion
No distinct types of Temple syndrome due to paternal 14q32.2 microdeletion are widely recognized.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or medicine can meaningfully delay the start of symptoms in Temple syndrome, because it is a genetic condition that is present before birth. Healthy habits like balanced eating, regular movement, and good sleep may help overall health and may lower the chance of problems such as excess weight gain, but they have not been shown to delay or prevent the condition itself. Regular early follow-up with a child health, hormone, and development team can help spot growth, feeding, learning, or puberty concerns sooner and treat them earlier, and while research is ongoing, this is the most helpful practical step right now.
What genetics can tell you about symptoms
Genetics can explain why people with Temple syndrome due to a paternal 14q32.2 microdeletion often share a pattern of symptoms, including low muscle tone in infancy, feeding difficulties early on, shorter height, early puberty, and learning or behavior differences. The exact size of the deleted segment and which nearby genes are affected can influence which features show up, how noticeable they are, and sometimes how early they begin, but symptoms can still vary quite a bit from one person to another. In other words, the genetic change helps predict the general syndrome, but it usually cannot forecast every symptom or how mild or severe daily challenges will be for one individual.
Causes and risk factors
Temple syndrome due to paternal 14q32.2 microdeletion happens when a small piece of the copy of chromosome 14 inherited from the father is missing. This is usually a new genetic change, but sometimes it is inherited from a parent with a hidden chromosome change. Other biological factors, such as growth and hormone patterns, can affect how strongly the features show up. Lifestyle and environmental factors do not cause this form of Temple syndrome, but nutrition, activity, sleep, and regular care can still shape overall health. Genetic testing can sometimes clarify your personal risk, especially when looking at the risk of Temple syndrome in future pregnancies.
What are the most common causes or risk factors?
Temple syndrome due to a paternal 14q32.2 microdeletion is caused by a small missing piece of chromosome 14 on the copy that comes from the father, which affects genes that help control growth and development. In many families, this happens as a new, random genetic change around the time of conception; less often, it is passed down because a parent carries the same deletion or another chromosome change that makes it more likely. There are no known lifestyle, diet, or environmental risk factors, and nothing a parent did during pregnancy is known to cause it.
Environmental and biological risk factors
When families look for risk factors for Temple syndrome due to paternal 14q32.2 microdeletion, the main finding is that clear environmental or other biological triggers have not been identified. Most cases seem to begin with a small missing piece of chromosome 14 that happens by chance in sperm formation or very early after conception. Because of that, there is usually nothing during pregnancy or in day-to-day life that clearly predicts or prevents it.
Temple syndrome due to paternal 14q32.2 microdeletion usually results from a chromosome change that happens randomly, not from a known illness, injury, or action during pregnancy. This change can arise during sperm formation or shortly after conception.
No specific medication, infection, pollutant, radiation exposure, or maternal health condition has been proven to specifically cause this exact microdeletion. In many families, doctors cannot identify any outside factor that raised the chance.
Because this condition is very rare, studies have not shown a consistent link with maternal or paternal age. For many living with Temple syndrome due to paternal 14q32.2 microdeletion, the deletion appears without a clear biological or environmental warning sign.
Genetic risk factors
In Temple syndrome due to paternal 14q32.2 microdeletion, the main genetic problem is a tiny missing piece of chromosome 14 on the copy inherited from the father. When people ask about the genetic causes of Temple syndrome due to paternal 14q32.2 microdeletion, the answer centers on loss of activity in genes from this region that normally need to work from the father’s side. People with the same risk factor can have very different experiences. Family risk depends largely on whether the deletion happened for the first time in the child or was passed down through the family.
Paternal deletion: A small missing segment at 14q32.2 removes or disrupts genes that should be active on the father’s chromosome 14. When that paternal gene activity is lost, Temple syndrome can develop.
Imprinting pattern: This part of chromosome 14 is controlled by parent-of-origin marking, a process called imprinting. The mother’s copy cannot fully make up for the missing paternal signal, so the same deletion matters most when it is on the paternal side.
New change: In many families, the microdeletion starts as a new genetic change in the child and is not found in either parent. In that situation, the chance of it happening again is usually low, although it is not always zero.
Inherited deletion: Sometimes the deletion is passed down through a family rather than happening for the first time. Because of imprinting, the same genetic change may cause Temple syndrome only when it is inherited from the father.
Balanced rearrangement: Some parents carry a chromosome reshuffle with no missing or extra DNA in themselves. This can increase the chance that a child inherits a 14q32.2 deletion, including the paternal deletion linked to Temple syndrome.
Lifestyle risk factors
Temple syndrome due to paternal 14q32.2 microdeletion is not caused by lifestyle habits, but daily routines can meaningfully affect growth, body composition, mobility, and long-term metabolic health. In this condition, how lifestyle affects Temple syndrome is most relevant for managing the tendency toward increased body fat, lower muscle mass and tone, and later risks such as insulin resistance. Diet, movement, sleep, and feeding patterns are especially important because their effects can be amplified in children and adults with this syndrome.
Excess calorie intake can more easily lead to rapid weight gain in Temple syndrome, especially when muscle mass is low and energy needs are modest. A structured eating pattern with appropriate portions can help limit obesity and reduce downstream metabolic strain.
Frequent sugary drinks, ultra-processed snacks, and low-fiber meals can worsen the risk of insulin resistance and unfavorable body fat gain seen in Temple syndrome. Meals centered on protein, fiber, and minimally processed foods may support steadier energy intake and better metabolic control.
Low activity can worsen reduced muscle strength, lower endurance, and excess fat accumulation in people with Temple syndrome. Regular age-appropriate exercise, including strength-building and aerobic activity, may improve mobility, body composition, and insulin sensitivity.
Long periods of sitting and high screen time can compound the low-energy-expenditure pattern that makes weight management difficult in Temple syndrome. Breaking up sedentary time with frequent movement may help preserve fitness and limit further fat gain.
Risk prevention
Temple syndrome due to paternal 14q32.2 microdeletion is a genetic condition, so there is no known way to prevent the syndrome itself from happening. Prevention usually means lowering the chance of complications, supporting growth and development, and catching problems early. Different people need different prevention strategies—there’s no single formula. Care is often tailored over time because needs can change from infancy to childhood and beyond.
Ongoing care with a pediatrician and the right specialists can help spot issues before they become harder to manage. For many living with Temple syndrome, regular visits are one of the best ways to prevent avoidable complications.
Checking height, weight, and growth pattern on a regular schedule can help the care team respond early if growth is too slow or weight gain is too fast. This can guide nutrition, activity, and treatment decisions for Temple syndrome.
Balanced meals and steady eating routines can help support growth in early childhood and reduce later problems with excess weight. Some may find that meeting with a dietitian helps turn day-to-day eating challenges into a realistic plan.
Regular physical activity can support muscle strength, fitness, bone health, and weight control. In Temple syndrome, choosing activities that fit a child’s abilities can make movement safer and easier to keep up.
Can you prevent Temple syndrome due to paternal 14q32.2 microdeletion?
No, Temple syndrome caused by a missing piece of chromosome 14 from the father usually cannot be prevented. This change is present from the very start of pregnancy and is not caused by anything a parent did or did not do. If there is a family history or a previous affected child, genetic counseling before pregnancy may help families understand the chance of it happening again, but it cannot guarantee prevention.
Transmission
Temple syndrome due to paternal 14q32.2 microdeletion is not infectious, so it cannot be caught from someone or passed through touch, coughing, sex, food, or daily contact. The genetic transmission of Temple syndrome due to paternal 14q32.2 microdeletion happens through a missing small piece of chromosome 14, and symptoms develop when that missing piece affects the copy that should come from the father.
For many living with Temple syndrome, this change is new in the child and was not caused by anything a parent did. In some families, it can be passed from parent to child, so if there is a known chromosome change in the family, genetic counseling can help explain how Temple syndrome is inherited and the chance of it happening again.
When to test your genes
Genetic testing is most useful when a child has a pattern such as poor growth before birth, low muscle tone, feeding problems, early puberty, or short stature, because confirming Temple syndrome can guide growth, hormone, and developmental care. Testing may also be considered if a parent carries a related chromosome change.
Diagnosis
Temple syndrome due to paternal 14q32.2 microdeletion is usually suspected when a child has a pattern of growth, feeding, muscle tone, and puberty changes that fit together rather than one single symptom alone. Doctors often look at birth history, growth over time, and physical features, then confirm the diagnosis with focused genetic testing. Getting a diagnosis is often a turning point toward answers and support.
Doctors first look for a recognizable pattern such as poor growth before birth, low muscle tone, early feeding problems, slower motor development, and later rapid weight gain or early puberty. These clinical features can raise suspicion for the diagnosis of Temple syndrome due to paternal 14q32.2 microdeletion, but they are not enough on their own to confirm it.
Care teams review pregnancy details, birth size, and how weight and height have changed over time. This helps show whether growth restriction started before birth and whether later growth or puberty changes fit the condition.
The exam may look for body and facial features that sometimes occur with Temple syndrome, along with signs such as small hands or feet and lower muscle tone. These findings can support the diagnosis and help guide which genetic tests are most useful.
Chromosome microarray is often used to look for the missing piece of chromosome 14 at 14q32.2 on the paternal copy. If a deletion is found, this can confirm the genetic cause in many people with Temple syndrome.
How is Temple syndrome due to paternal 14q32.2 microdeletion diagnosed?
Doctors usually first suspect Temple syndrome from a pattern of signs such as slow growth before or after birth, low muscle tone, feeding problems in infancy, short height, and often earlier-than-expected puberty, along with a review of development and family history. Because these signs can look like other conditions, the diagnosis is confirmed with genetic testing that checks the chromosome 14 copy from the father for a small missing piece at the 14q32.2 region or other changes in that same area that affect how the genes work. The work-up may also include growth measurements, puberty checks, and sometimes hormone tests to understand how the condition is affecting the child.
Stages of Temple syndrome due to paternal 14q32.2 microdeletion
Temple syndrome due to paternal 14q32.2 microdeletion does not have defined progression stages. This is because it is a genetic condition identified by a pattern of features rather than a disease that moves through clear step-by-step phases over time. Many living with Temple syndrome due to paternal 14q32.2 microdeletion are diagnosed after concerns such as poor growth before birth, low muscle tone, feeding problems in infancy, or later signs like early puberty and short stature; early symptoms of Temple syndrome due to paternal 14q32.2 microdeletion can vary from one child to another. Doctors usually start with a conversation about growth, development, and family history, then use a physical exam and genetic testing to confirm the diagnosis and guide follow-up over time.
Outlook and prognosis
The outlook for people with Temple syndrome due to paternal 14q32.2 microdeletion is often compatible with a normal or near-normal life expectancy, especially with early support for feeding, growth, puberty, learning, and behavior. Infants may have significant hypotonia and feeding difficulties, but these usually improve, while later childhood and adolescence can bring short stature, early puberty, increasing body fat, and metabolic risks that benefit from regular endocrine follow-up. Developmental outcomes are variable: some children have mild learning or speech difficulties, while others need more substantial educational and therapy support, yet many achieve good functional independence. Long-term prognosis is strongly influenced by how well complications such as obesity, insulin resistance, and psychosocial or behavioral challenges are recognized and managed. Published data do not suggest a characteristic increase in mortality from the syndrome itself, but precise mortality estimates are not available because the condition is very rare and long-term follow-up studies are limited.
Long-term effects
Temple syndrome due to paternal 14q32.2 microdeletion can affect growth, body composition, development, and puberty over many years. In medical terms, these are sometimes called late effects or chronic symptoms, although for a genetic condition they are better thought of as long-term features. Many living with Temple syndrome have mild to moderate effects, but the pattern can differ from one person to another.
Many people with Temple syndrome remain shorter than expected as they grow, and some have a smaller build overall. Early puberty can limit the time available for growth, which may further reduce adult height.
A tendency to gain weight around the trunk often becomes more noticeable in later childhood or adolescence. Over time, daily routines may need to adjust because extra weight can raise the risk of insulin resistance and other metabolic problems.
Puberty often starts earlier than usual in Temple syndrome, sometimes with breast development or pubic hair appearing at a young age. This can shape growth, emotional development, and bone maturation over the long term.
Low muscle tone and reduced muscle strength can continue beyond infancy and early childhood. For many, this can mean tiring more easily with stairs, sports, or long walks than other children the same age.
How is it to live with Temple syndrome due to paternal 14q32.2 microdeletion?
Living with Temple syndrome can look very different from one person to the next, but for many it means growing up with low muscle tone, short stature, early puberty, and learning or behavior challenges that can affect school, friendships, confidence, and day-to-day independence. Some people also deal with feeding difficulties early in life and a tendency toward weight gain later, so daily routines often include regular medical visits, therapy, nutrition support, and extra structure at home and school. For parents, siblings, and other caregivers, this can mean more appointments, more planning, and sometimes emotional strain, but with the right support many people with Temple syndrome make steady progress and build meaningful, connected lives.
Treatment and drugs
Treatment for Temple syndrome due to paternal 14q32.2 microdeletion is based on the problems it causes, so care often involves a team that may include a pediatrician, hormone specialist, dietitian, physical therapist, and speech or feeding therapist. In infancy, treatment may focus on poor muscle tone, slow feeding, and growth, while later care often addresses short height, weight gain, learning or behavior needs, and early puberty. Doctors may recommend growth hormone for some children with Temple syndrome, and some may need medicines to slow unusually early puberty or to treat related hormone problems. Treatment plans often combine several approaches, with regular follow-up to track growth, development, eating, sleep, and school functioning over time. Because early symptoms of Temple syndrome can change with age, treatment is usually adjusted as a child grows.
Can you cure Temple syndrome due to paternal 14q32.2 microdeletion?
No, there is currently no cure for Temple syndrome due to paternal 14q32.2 microdeletion, because it is caused by a missing piece of genetic material and is present from birth. Treatment cannot fix the underlying genetic change, but it can help manage problems such as slow growth, feeding trouble, weak muscles, early puberty, and learning or behavior challenges. Regular care and supportive therapies can make a real difference and are tailored to each person’s needs.
Non-drug treatment
Day-to-day care for people living with Temple syndrome due to paternal 14q32.2 microdeletion usually centers on development, feeding, movement, learning, and family support rather than on medicines alone. Because Temple syndrome can affect muscle tone, growth, appetite, puberty, and learning in different ways, care is often tailored to the needs that matter most at a given age. For many, treatment begins not at the pharmacy, but with therapies and routines that support strength, communication, nutrition, and school participation. Regular follow-up with a coordinated team can help problems be spotted early and managed in a practical way.
Early therapy services can help babies and young children build motor, speech, and daily living skills. This is especially helpful when early symptoms of Temple syndrome include low muscle tone, feeding trouble, or slower developmental progress.
Physical therapy can improve strength, balance, posture, and coordination when low muscle tone makes movement harder. Many living with Temple syndrome benefit from exercises and play-based activities that support sitting, walking, stair climbing, and endurance.
Occupational therapy helps with hand use, dressing, feeding, writing, and other everyday tasks. Some may find it also helps with sensory differences and with planning the small steps needed to complete an activity.
Speech and language therapy can support both speaking and understanding, as well as social communication. If feeding is affected, the same team may also help with chewing, swallowing, and safer mealtime habits.
Your genes may have an impact on how drugs work for you
For people living with Temple syndrome caused by a small missing piece of chromosome 14, treatment is usually aimed at day-to-day issues such as growth, early puberty, feeding, or blood sugar problems, rather than at the genetic change itself. At this time, there are no well-established examples showing that this syndrome by itself consistently changes how common medicines work, so care is usually based on symptoms, age, and how someone responds over time. In some cases, doctors may still adjust doses carefully and watch closely for side effects, because children and adults with rare genetic conditions can vary in how they handle treatment even when no specific medicine-gene effect is known.
Pharmacological treatments
Treatment for Temple syndrome due to paternal 14q32.2 microdeletion is usually focused on specific problems rather than one single medicine for the whole condition. Many living with Temple syndrome may be offered medicine to support growth, puberty, or hormone balance, depending on age and symptoms. Not everyone responds to the same medication in the same way, so care is usually tailored and reviewed over time.
Recombinant human growth hormone is the medicine most often used when Temple syndrome causes short stature or poor growth. It can help improve height gain and body composition, especially in childhood when started after specialist assessment.
Estrogen with later progesterone for girls, or testosterone for boys, may be used if puberty is delayed or does not progress as expected. This can support sexual development, bone health, and some of the day-to-day concerns families notice during the early symptoms of Temple syndrome.
Gonadotropin-releasing hormone agonists such as leuprolide or triptorelin may be used if puberty starts too early. Slowing early puberty can help protect adult height and give development more time to unfold at a steadier pace.
Metformin may be considered in some children or adults with insulin resistance, prediabetes, or weight-related metabolic problems. It is not a core treatment for Temple syndrome due to paternal 14q32.2 microdeletion, but it can help when blood sugar control becomes part of the picture.
Genetic influences
For many families, the big question is why poor growth before birth, early feeding problems, and later puberty concerns can appear together in Temple syndrome due to paternal 14q32.2 microdeletion. This form happens when a small piece of chromosome 14 is missing from the copy inherited from the father. The missing segment sits in an imprinted region at 14q32.2, where the mother’s and father’s copies are meant to work differently, so losing the father’s copy disrupts genes in that area that guide growth, body composition, and development. This is a genetic change, not something caused by diet, stress, or anything a parent did during pregnancy. In most children, the microdeletion is a new event, but some families may have a parent with a chromosome rearrangement that raises the chance of it happening again. Genetic testing can confirm this specific cause of Temple syndrome, and genetic counseling can help relatives understand recurrence risk.
Is Temple syndrome due to paternal 14q32.2 microdeletion genetic?
Genetics are central to Temple syndrome due to paternal 14q32.2 microdeletion, because it results from changes in a specific region of chromosome 14. Most cases are not caused by lifestyle or environment, though the exact genetic change can vary between families.
Having a genetic risk is not necessarily a diagnosis
Genetic changes are a normal part of human biology and are widespread in the general population. Most of these changes do not directly affect health and simply reflect natural human diversity. For many genes, carrying a change linked to a condition suggests a possible connection rather than a definite diagnosis, especially when several genes and environmental factors play a part. In some cases, though, a single well-characterized change in a specific gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
In Temple syndrome due to paternal 14q32.2 microdeletion, the genetic finding often helps doctors shape treatment, even though there is no medicine that can restore the missing paternal gene activity itself. Because the early symptoms of Temple syndrome can overlap with other growth and puberty conditions, the genetic diagnosis helps avoid a one-size-fits-all approach. Instead, treatment is usually aimed at the specific issues someone has, such as poor growth, feeding problems, early puberty, or later weight gain. That can affect whether doctors consider options like growth hormone for short stature or medicines to slow puberty if it starts too early or moves too quickly. Genetics is only one factor, because age, nutrition, activity level, and other health conditions also affect which treatments are safest and most helpful. For many living with Temple syndrome, this means the care plan is personalized and may be adjusted over time as needs change.
Interactions with other conditions
Day-to-day, people with Temple syndrome due to paternal 14q32.2 microdeletion may not only deal with growth and puberty differences, but also with health problems that can build on them over time. Some early symptoms of Temple syndrome, such as low muscle tone and feeding difficulties in infancy, can overlap with other conditions, so doctors often look carefully for a broader pattern rather than assuming there is a separate illness. As children get older, Temple syndrome is linked with a higher chance of excess body fat, which can raise the risk of insulin resistance, type 2 diabetes, fatty liver disease, and sleep apnea. Doctors call it a comorbidity when two conditions occur together. Early or fast-moving puberty can also affect final height and may add to concerns about weight and metabolic health, so hormone and growth follow-up is often part of care. Interactions can look very different from person to person, but regular checks for weight changes, blood sugar, liver health, and sleep problems can help catch related conditions early.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Temple syndrome due to paternal 14q32.2 microdeletion?
Because Temple syndrome can cause low muscle tone, feeding trouble, slow growth, short height, and sometimes early puberty, it is often confused with Prader-Willi syndrome or Silver-Russell syndrome, which can look similar in babies and young children. Doctors may also consider hormone problems, such as low thyroid function or other causes of early puberty, as well as a few other rare genetic conditions if the pattern of symptoms is not a close match.
History
Temple syndrome due to paternal 14q32.2 microdeletion was not recognized right away as its own condition. For many living with it, the story has often started with a mix of signs that seemed unrelated at first, such as slow growth before birth, feeding difficulties in infancy, or puberty starting earlier than expected later in childhood. That made early cases easy to miss or group under other diagnoses.
As medical science evolved, doctors began to notice that some children shared a similar pattern of growth, body shape, and development. Initially understood only through symptoms, later Temple syndrome was separated more clearly from other growth and imprinting disorders as specialists compared children over time and across families. This was an important shift, because it helped explain why one child might be very small in early life while another was first brought to medical attention for rapid weight gain or early puberty.
In the late 20th and early 21st centuries, better chromosome testing and newer genetic methods made the picture clearer. Researchers learned that Temple syndrome can happen when a specific region on chromosome 14 is not working in the usual parent-of-origin pattern, and that in some people this involves a small missing piece of that region. Not every early description was complete, yet together they built the foundation of today’s knowledge and helped doctors recognize the condition earlier.
That growing understanding has changed day-to-day care. In the past, families might spend years looking for a reason behind poor growth, low muscle tone, or the early symptoms of Temple syndrome, only to receive different explanations at different ages. Today, awareness is still limited because the condition is rare, but diagnosis is more precise than it used to be, which can help guide monitoring for growth, puberty, nutrition, and learning needs.
The history of Temple syndrome also shows how medicine often moves forward: first by noticing patterns, then by refining them with better testing. Knowing this background can make a delayed diagnosis feel a little less confusing. It also helps explain why older medical records may use different descriptions even when they were likely referring to the same condition.